Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06314516 · ClinicalTrials.gov registry record
Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes
A clinical trial, sponsored by Benaroya Research Institute.
- Completed
- Registry status
- 1,717
- Enrollment target
NCT06314516: Completed study, sponsored by Benaroya Research Institute.
NCT06314516 is a clinical trial that has completed, run by Benaroya Research Institute. The registered enrollment target is 1,717 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06314516 has completed, sponsored by Benaroya Research Institute.
- COMPLETED
- Registry status
- 1,717 participants
- Enrollment target
Study Summary
Prospective multicenter longitudinal (observational) study recruiting from tertiary centers for the surgical management of esophageal cancer; Virginia Mason Medical Center (Seattle, USA) and St Mary's Hospital (Imperial College, London, UK). This is intended to be a pilot study.
Primary Outcome
Establish the effect of patient and disease-specific factors on body composition in a global cohort of patients undergoing esophagectomy for cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,717 participants |
| Start Date | 2017-12-27 |
| Est. Completion | 2024-02-28 |
What the finished NCT06314516 record still lists
NCT06314516 is an observational study that tracks outcomes without assigning an intervention. Its 1,717 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT06314516 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06314516 about?
NCT06314516 is a clinical study titled "Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes". Prospective multicenter longitudinal (observational) study recruiting from tertiary centers for the surgical management of esophageal cancer; Virginia Mason Medical Center (Seattle, USA) and St Mary's Hospital (Imperial College, London, UK). This is intended to be a pilot study.
What is the current status of trial NCT06314516?
This trial is currently completed. The enrollment target is 1,717 participants. The study started on 2017-12-27. Estimated completion is 2024-02-28.
Who is sponsoring clinical trial NCT06314516?
This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT06898034 · 1,725 participants
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
- NCT07304531 · 1,705 participants
First To Know Pregnancy Test - Clinical Evaluation Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI